PHARMACOLOGICAL AGENTS AFFECTING THE CARDIOVASCULAR SYSTEM: CLINICAL SIGNIFICANCE OF BETA-BLOCKERS, CALCIUM CHANNEL BLOCKERS AND ANTIARRHYTHMIC MEDICINES
Keywords:
cardiovascular pharmacology, beta-blockers, calcium channel blockers, antiarrhythmics, clinical significanceAbstract
This article analyzes three major cardiovascular pharmacological groups: beta-blockers, calcium channel blockers and antiarrhythmic agents. It uses an IMRAD narrative review design and connects mechanism of action with clinical significance, safety risks and health-system relevance. The results show that cardiovascular medicines are effective only when their pharmacodynamic profile is matched with disease mechanism, patient phenotype and monitoring needs. Uzbekistan-specific cardiovascular burden indicators are included to demonstrate why rational cardiovascular pharmacotherapy is a major public health issue.
References
Azizova S.S. Farmakologiya. Toshkent: Abu Ali ibn Sino nomidagi tibbiyot nashriyoti, 1994.
Mavlyanov I.R., Mahkamova R.K., Kats P. Klinik farmakologiya. Toshkent: tibbiyot oliy ta’lim muassasalari uchun darslik.
Mamadov Yu.M. Klinik farmakologiya. Toshkent, 2010.
Gadayev A.G. Ichki kasalliklar propedevtikasi. Toshkent, 2018.
Arslonov Y.L., Nazarov T.A., Bobomurodov A.A. Ichki kasalliklar. Toshkent: Ilm Ziyo, 2013.
World Health Organization. Cardiovascular diseases (CVDs) fact sheet, 2025.
World Heart Federation. World Heart Observatory: Uzbekistan country profile.
European Society of Cardiology. ESC Atlas of Cardiology: Uzbekistan CVD statistics, October 2024.
Gaziano T.A. Cardiovascular Disease. Disease Control Priorities/NCBI Bookshelf.
World Heart Federation. World Heart Report 2025.